Welcome to our dedicated page for Ibex SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IBEX Limited (IBEX) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. As a Nasdaq-listed Bermuda company and emerging growth issuer, IBEX files a range of documents with the U.S. Securities and Exchange Commission that detail its operations, governance, and financial performance.
Key filings include Form 10-K and related annual reports, which present audited financial statements, risk factors, and management’s discussion of results for the fiscal year. Quarterly results and updates are frequently communicated through Form 8-K, where ibex furnishes press releases covering revenue, net income, adjusted net income, adjusted EBITDA, and earnings per share, as well as guidance ranges for future periods.
Investors can also review proxy materials such as the DEF 14A, which describe the board structure, director independence, committee composition, executive compensation programs, long-term incentive plans, and changes in status such as the transition away from controlled company exemptions. Other 8-K filings address governance developments, including the formation of a formal Nominating Committee and related board decisions.
Stock Titan enhances these filings with AI-powered summaries and explanations that highlight important sections, clarify technical language, and surface items that may matter to shareholders, such as governance changes, compensation plans, or capital allocation decisions. Real-time updates from EDGAR ensure that new IBEX filings, including Forms 3, 4, and 5 for insider transactions when available, appear promptly.
Use this page to explore IBEX’s historical and current SEC record, understand how management presents its strategy and performance, and quickly grasp the implications of lengthy documents through AI-generated insights.
IBEX Ltd. filed a Form 144/A disclosing notice of proposed sale of 6,000 common shares. The filing lists recent sales by a reporting person, including Robert Dechant who sold 6,000 shares on
Robert Dechant reported a proposed sale of 6,000 common shares of IBEX under a Rule 144 notice. The filing lists two prior sales in the past three months: 6,000 shares sold on
IBEX Ltd Chief Executive Officer and director Robert Thomas Dechant reported open-market sales of company common shares on two consecutive days. He sold 6,000 common shares on February 17 at a weighted average price of
Both transactions were executed as multiple trades within stated price ranges, with detailed trade-level information available on request. Following these sales, Dechant directly owns 293,406 IBEX common shares.
Ibex Ltd reported a Rule 144 notice for the sale of 6,000 common shares by a selling party represented by RBC Capital Markets. The filing lists the sale date as 02/17/2026 and an aggregate amount of $177,786.00. The shares trace to an RSA vest dated 12/28/2018.
Ibex had a shareholder file a notice to sell 6,000 shares of its common stock under Rule 144. The planned sale, with an aggregate market value of $177,786.00, is expected around 02/17/2026 through RBC Capital Markets LLC on Nasdaq.
The 6,000 shares were acquired on 12/28/2018 via an RSA vest from the issuer. Ibex had 13,405,520 shares of this class outstanding, providing context for the size of the proposed sale.
IBEX Ltd’s Chief Sales/Marketing Officer, Julie K. Casteel, reported equity compensation activity in company common shares. On February 6, 2026, she acquired 97,126 restricted shares at $0 per share through a grant tied to a performance share award based on revenue and EBITDA targets.
On the same date, 8,649 shares were disposed of at $34.98 per share, representing shares withheld to cover taxes upon vesting. After these transactions, she directly held 116,794 common shares. One-third of the performance-based shares vested on February 6, 2026, with additional one-third tranches scheduled to vest on February 6, 2027 and February 6, 2028, subject to her continued service.
IBEX Ltd’s Chief Legal Officer, Christina Alice Trofimuk-O'Connor, reported equity compensation activity. On February 6, 2026, she acquired 19,557 common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
On the same date, 2,176 common shares were disposed of at $34.98 to cover taxes due at vesting. After these transactions, she directly held 31,335 IBEX common shares. One-third of the award vested on February 6, 2026, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028, subject to her continued service.
IBEX Ltd’s Chief Operating Officer, David Martin Afdahl, reported equity compensation activity. On February 6, 2026, he acquired 109,708 common shares at $0 as a restricted stock award tied to performance goals. On the same date, 13,917 shares were disposed of at $34.98 to cover taxes on the vesting. After these transactions, he directly owned 152,902 common shares. The award stems from an April 20, 2022 performance share grant that vests in three equal installments through 2028, contingent on continued service.
IBEX Ltd's Chief Financial Officer, Taylor C. Greenwald, reported equity compensation activity involving the company’s common shares. On February 6, 2026, the CFO acquired 20,000 common shares at $0 per share as a restricted stock award tied to a May 31, 2024 performance share grant based on revenue and EBITDA targets.
On the same date, 2,121 common shares were disposed of at $34.98 per share to cover tax withholding upon vesting. After these transactions, the CFO directly beneficially owned 54,361 common shares. One-third of the performance-based shares vested on February 6, 2026, with additional one‑third tranches scheduled to vest on February 6, 2027 and February 6, 2028, subject to continued service.
IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal reported several equity transactions. On February 11, 2026 he received a grant of 25,000 Restricted Stock Units, each representing one common share, vesting in four equal annual installments starting February 11, 2027, subject to continued service.
On February 6, 2026 he acquired 12,149 common shares at no cost upon vesting of an earlier performance share award tied to revenue and EBITDA targets, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028. That same day he sold 1,660 shares at $34.98 per share, described as shares withheld for tax purposes. After these transactions he directly owned 42,185 common shares.